Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a sensor to detect methylmercury toxicity. | Sci Rep | 2024 | 39294331 | PubTator, text mining | PubMed |
| Endogenous electrophiles and peroxymonocarbonate can link tyrosine phosphorylation cascades with the cytosolic TXNRD1 selenoprotein and the KEAP1/NRF2 system. | Curr Opin Chem Biol | 2024 | 39243480 | PubTator, text mining | PubMed |
| A machine learning based EMA-DCPM algorithm for production scheduling. | Sci Rep | 2024 | 39242680 | PubTator, text mining | PubMed |
| Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) Ameliorate Heart Failure through Reductions in Oxidative Stress: A Systematic Review and Meta-Analysis. | Antioxidants (Basel) | 2024 | 39199201 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitor, Trichostatin A mitigates ionizing radiation induced redox imbalance by regulating NRF2/GPX4/PINK1/PARKIN signaling in mice intestine. | Mol Biol Rep | 2024 | 39198316 | PubTator, text mining | PubMed |
| Optimizing protein sequence classification: integrating deep learning models with Bayesian optimization for enhanced biological analysis. | BMC Med Inform Decis Mak | 2024 | 39192227 | PubTator, text mining | PubMed |
| Unveiling the anticancer potential of Pestalotioprolide E, an unexplored macrolide: Targeting TRXR1-TRX1-ASK1-P38 signaling cascade in triple-negative breast cancer. | Toxicol In Vitro | 2024 | 39173682 | PubTator, text mining | PubMed |
| DNA Methylation Patterns Associated with Tinnitus in Young Adults-A Pilot Study. | J Assoc Res Otolaryngol | 2024 | 39147981 | PubTator, text mining | PubMed |
| Calycosin activates Nrf2/Keap1 signaling to ameliorate hydrogen peroxide-induced spinal cord neuron death and mitochondrial dysfunction. | J Biochem Mol Toxicol | 2024 | 39132830 | PubTator, text mining | PubMed |
| Protocol for assaying irreversible inhibitors of thioredoxin reductase 1. | STAR Protoc | 2024 | 39116197 | PubTator, text mining | PubMed |
| Unique features of KGN granulosa-like tumour cells in the regulation of steroidogenic and antioxidant genes. | PLoS One | 2024 | 39110703 | PubTator, text mining | PubMed |
| Identification of Key Genes Associated with Polycystic Ovarian Syndrome and Endometrial and Ovarian Cancer through Bioinformatics. | J Hum Reprod Sci | 2024 | 39091436 | PubTator, text mining | PubMed |
| Unresolved questions regarding cellular cysteine sources and their possible relationships to ferroptosis. | Adv Cancer Res | 2024 | 39069366 | PubTator, text mining | PubMed |
| Pro-Oxidant Auranofin and Glutathione-Depleting Combination Unveils Synergistic Lethality in Glioblastoma Cells with Aberrant Epidermal Growth Factor Receptor Expression. | Cancers (Basel) | 2024 | 39001381 | PubTator, text mining | PubMed |
| Memory effects of prior subculture may impact the quality of multiomic perturbation profiles. | Proc Natl Acad Sci U S A | 2024 | 38976734 | PubTator, text mining | PubMed |
| Subcellular Localization of Thioredoxin/Thioredoxin Reductase System-A Missing Link in Endoplasmic Reticulum Redox Balance. | Int J Mol Sci | 2024 | 38928353 | PubTator, text mining | PubMed |
| The rheumatoid arthritis drug auranofin exerts potent anti-lymphoma effect by stimulating TXNRD-mediated ROS generation and inhibition of energy metabolism. | Redox Biol | 2024 | 38909408 | PubTator, text mining | PubMed |
| The diagnostic potential role of thioredoxin reductase and TXNRD1 in early lung adenocarcinoma: A cohort study. | Heliyon | 2024 | 38882339 | PubTator, text mining | PubMed |
| Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer. | Transl Oncol | 2024 | 38870678 | PubTator, text mining | PubMed |
| Comparison of software packages for detecting unannotated translated small open reading frames by Ribo-seq. | Brief Bioinform | 2024 | 38842510 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=17